Ovascience Inc (NASDAQ:OVAS) Institutional Investor Positioning

June 16, 2018 - By Kurt Siggers

OvaScience, Inc. (NASDAQ:OVAS) Logo

Sentiment for Ovascience Inc (NASDAQ:OVAS)

Ovascience Inc (NASDAQ:OVAS) institutional sentiment decreased to 0.71 in Q1 2018. Its down -0.12, from 0.83 in 2017Q4. The ratio dived, as 17 investment managers started new and increased stock positions, while 24 decreased and sold their equity positions in Ovascience Inc. The investment managers in our partner’s database now have: 9.80 million shares, down from 15.55 million shares in 2017Q4. Also, the number of investment managers holding Ovascience Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 12 Reduced: 12 Increased: 9 New Position: 8.

OvaScience, Inc., a fertility company, discovers, develops, and commercializes fertility treatment options for women worldwide. The company has market cap of $33.77 million. The companyÂ’s patented technology is based on the discovery of egg precursor cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It currently has negative earnings. It engages in developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize the fertility treatment consisting of AUGMENT to enhance the energy and health of the womanÂ’s eggs by using mitochondria from a woman's EggPC cells; OvaTure to produce mature fertilizable eggs from a womanÂ’s own EggPC cells without the need for hormone injections; OvaPrime treatment is used to replenish a woman's egg reserve by transferring the EggPCs from woman's own ovaries; and OvaXon for the prevention of inherited human disease and improvement of animal health.

The stock decreased 1.61% or $0.0155 during the last trading session, reaching $0.9445. About 214,709 shares traded. OvaScience, Inc. (NASDAQ:OVAS) has declined 28.40% since June 16, 2017 and is downtrending. It has underperformed by 40.97% the S&P500.

Sabby Management Llc holds 0.14% of its portfolio in OvaScience, Inc. for 1.46 million shares. Broadfin Capital Llc owns 545,282 shares or 0.07% of their US portfolio. Moreover, Knott David M has 0.04% invested in the company for 112,000 shares. The New York-based Awm Investment Company Inc. has invested 0.02% in the stock. Gmt Capital Corp, a Georgia-based fund reported 801,345 shares.

OvaScience, Inc. (NASDAQ:OVAS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: